InvestorsHub Logo
Followers 5
Posts 2114
Boards Moderated 0
Alias Born 07/13/2020

Re: None

Friday, 04/23/2021 2:07:59 AM

Friday, April 23, 2021 2:07:59 AM

Post# of 1949
$SWISF "As we near completion and reporting of the results of the HS 12 - 01 clinical trial, Sekur provides Hemostemix with the ultimate Switzerland based and encrypted email security that enables us to send no size limit attachments and comply with our regulator's secure communication standards," stated Thomas Smeenk, CEO.